Question 1

What are the potential benefits of participating in this trial compared to standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer clinical trial (NCT04257786). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the trial affect my treatment timeline and follow-up care?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer clinical trial (NCT04257786). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer clinical trial (NCT04257786). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer clinical trial (NCT04257786). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience complications during treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer clinical trial (NCT04257786). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel or logistical considerations I should be aware of if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer clinical trial (NCT04257786). Contact the study team or your healthcare provider for specific answers.

What this study is about